The 10th Annual International Society For Antiviral Research ConferenceGrand Hyatt, Atlanta, Georgia
April 6-11, 1997 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! The Tenth Annual International Society For Antiviral Research (ISAR) Conference provides an "interdisciplinary forum where investigators involved in basic, applied, and clinical research worldwide can convene to review recent developments in all areas of antiviral research." Specific topics covered in the 1997 program include "synthesis and chemistry, biochemistry and mechanism of action, molecular biology and targeting, in vitro evaluation, animal models, pharmacokinetics, toxicology and clinical trials." The conference includes "overview" speakers, oral presentations and poster presentations. ISAR was created in 1987 to advance and disseminate knowledge in all areas of antiviral research. The society is a non-profit scientific organization with approximately 1,000 members representing 30 countries. Generally, the presentations are on antiviral compounds not yet licensed for use or for licensed drugs at doses or indications not yet licensed. These reports cover a few selected HIV and HBV presentations. They are intended solely to give an account of those presentations and should not be inferred to give any recommendation for clinical usage. Conference Summations
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by The Body PRO. It is a part of the publication The 10th Annual International Society For Antiviral Research Conference.
|
|